hydrazine has been researched along with Thrombophilia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Fijnheer, R; Huisman, A; Koene, HR; Poolen, GC; Schutgens, REG; Thielen, N; Urbanus, RT; van Bladel, ER; van Dijk, WEM; van Galen, KPM | 1 |
Balduini, CL; Pecci, A; Rodeghiero, F | 1 |
Barcellini, W; Cantoni, S; Caparrotti, G; Carpenedo, M; Carrai, V; Crea, E; Di Nicola, M; Di Renzo, N; Fanin, R; Ferla, V; Liberati, AM; Paoloni, F; Santoro, C; Simonetti, F; Tuniz, E; Veneri, D; Volpetti, S; Zaja, F | 1 |
Barsam, S; Bussel, JB; Ghanima, W; Lee, SY; Miller, A; Sandset, PM | 1 |
1 review(s) available for hydrazine and Thrombophilia
Article | Year |
---|---|
Thrombopoietin receptor agonists in hereditary thrombocytopenias.
Topics: Benzoates; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Genetic Association Studies; Genetic Heterogeneity; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Hydrazines; Primary Myelofibrosis; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Risk; Thrombocytopenia; Thrombophilia; Thrombopoiesis; Thrombopoietin | 2018 |
3 other study(ies) available for hydrazine and Thrombophilia
Article | Year |
---|---|
Evaluation of the procoagulant state in chronic immune thrombocytopenia before and after eltrombopag treatment-a prospective cohort study.
Topics: Adult; Factor VIII; Humans; Hydrazines; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Thrombin; Thrombocytopenia; Thrombophilia; von Willebrand Factor | 2023 |
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Benzoates; Combined Modality Therapy; Drug Resistance; Female; Humans; Hydrazines; Immunoglobulins, Intravenous; Italy; Male; Middle Aged; Platelet Count; Portal Vein; Postoperative Complications; Premedication; Preoperative Care; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Retrospective Studies; Salvage Therapy; Splenectomy; Thrombophilia; Thrombopoiesis; Thrombopoietin; Venous Thrombosis; Young Adult | 2016 |
Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.
Topics: Benzoates; Blood Coagulation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemorrhage; Humans; Hydrazines; Platelet Count; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Retrospective Studies; Thrombophilia; Thrombopoietin; Venous Thrombosis | 2012 |